e-Drug3D 206 |
DESERPIDINE DISCONTINUED
|
cas 131-01-1 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
NATURAL MOLECULE (link) | PK parameters |
Target TARGET ANGIOTENSIN-CONVERTING ENZYME |
DrugCentral Synaptic vesicular amine transporter UNIPROT Q05940 SLC18A2 |
Download SDF file | Yohimban-16-carboxylic acid, 17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)- Formula: Calculated chemical properties: MW 578.64 NB_atoms 42 XLogP 4.16 PSA 91.475 NB_HD 1 NB_HA 10 fsp3 0.50 Lipinski(0=no;1=yes) 0 |
FDA NDA 088452 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) METHYCLOTHIAZIDE AND DESERPIDINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 088486 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) METHYCLOTHIAZIDE AND DESERPIDINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 010796 (pdf not found) INN (DESERPIDINE) HARMONYL (ABBVIE) APPROVAL= AP YEAR= 1957 NEWMOLECULARENTITY DISCONTINUED NDA 012148 (pdf not found) INN (DESERPIDINE ; HYDROCHLOROTHIAZIDE) ORETICYL 25 (ABBVIE) APPROVAL= AP YEAR= 1959 DISCONTINUED NDA 012775 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) ENDURONYL (ABBOTT) APPROVAL= AP YEAR= 1961 DISCONTINUED |
Other links: |